Xr Securities LLC Axsome Therapeutics, Inc. Call Options Transaction History

Xr Securities LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Jan 03, 2023	BUY	$39.94 - $79.72 $655,016 - $1.31 Million	16,400 New	16,400 $695,000
Q1 2020 Apr 09, 2020	SELL	$41.2 - $101.31 $181,280 - $445,764	-4,400 Closed	0 $0
Q4 2019 Jan 06, 2020	BUY	$16.71 - $106.24 $73,524 - $467,456	4,400 New	4,400 $238,000

327

38M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.56B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Xr Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Xr Securities LLC with notifications on news.